Literature DB >> 34474141

Non-neglectable therapeutic options for age-related macular degeneration: A promising perspective from traditional Chinese medicine.

Yuli Li1, Xing Li2, Xiaoya Li1, Zhihong Zeng3, Niall Strang4, Xinhua Shu5, Zhoujin Tan6.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Age-related macular degeneration (AMD) is a chronic neurodegenerative disease which causes irreversible central vision loss among the elderly population. Traditional Chinese Medicine (TCM), including formulas, acupuncture and herbs, has been used in the treatment of AMD for thousands of years and is currently used by many AMD patients around the world. AIM OF THE REVIEW: A comprehensive, in-depth literature review examining the use of TCM in the treatment of AMD has yet to be compiled. This review will improve current knowledge relating to the use of TCM and will open new avenues of exploration in developing new drugs for the treatment of AMD.
METHODS: A literature search of the PubMed database, Web of Science, Google Scholar and China National Knowledge Infrastructure (CNKI) was performed using relevant terms and keywords related to TCM in the treatment of AMD. Related books, PhD and master's theses were also researched.
RESULTS: The TCM-based interpretation of AMD has been used to establish a theoretical foundation for understanding the effect of TCM formulas and acupuncture on AMD. The possible mechanism of action of common Chinese herbs has also been discussed in detail.
CONCLUSION: TCM is a promising treatment option of AMD patients. However, lack of rigorous scientific evidence has limited the impact and uptake of TCM therapy. Future research should focus on improving understanding of the mechanism of action and bioactive components of TCM therapies.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Age-related macular degeneration; Pathogenesis; Therapy; Traditional Chinese medicine

Mesh:

Substances:

Year:  2021        PMID: 34474141     DOI: 10.1016/j.jep.2021.114531

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  5 in total

Review 1.  Novel Eye Drop Delivery Systems: Advance on Formulation Design Strategies Targeting Anterior and Posterior Segments of the Eye.

Authors:  Yaru Wang; Changhong Wang
Journal:  Pharmaceutics       Date:  2022-05-27       Impact factor: 6.525

2.  Exploration of the Specific Pathology of HXMM Tablet Against Retinal Injury Based on Drug Attack Model to Network Robustness.

Authors:  Yujie Xi; Yan Miao; Rui Zhou; Maolin Wang; Fangbo Zhang; Yu Li; Yi Zhang; Hongjun Yang; Feifei Guo
Journal:  Front Pharmacol       Date:  2022-03-25       Impact factor: 5.810

Review 3.  Nutraceuticals and Food-Grade Lipid Nanoparticles: From Natural Sources to a Circular Bioeconomy Approach.

Authors:  Cristina Blanco-Llamero; Joel Fonseca; Alessandra Durazzo; Massimo Lucarini; Antonello Santini; Francisco J Señoráns; Eliana B Souto
Journal:  Foods       Date:  2022-08-03

4.  Clinical Effect of Tongmai Fuming Decoction on Neovascular Ophthalmopathy.

Authors:  Lei Lei Yang; Feng Zhou; Qi Xu; Ting Ye; Hong Xiong
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-18       Impact factor: 2.650

Review 5.  Therapeutic Approaches for Age-Related Macular Degeneration.

Authors:  Ruth M Galindo-Camacho; Cristina Blanco-Llamero; Raquel da Ana; Mayra A Fuertes; Francisco J Señoráns; Amélia M Silva; María L García; Eliana B Souto
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.